Earnings Feed
Start Free
Home/Filings/4/0001140361-12-007047
4//SEC Filing

Zankel Todd 4

Accession 0001140361-12-007047

CIK 0001070698other
View on SEC.govCompany Profile

Filed

Feb 9, 7:00 PM ET

Accepted

Feb 10, 5:45 PM ET

Size

40.1 KB

Accession

0001140361-12-007047

Insider Transaction Report

Form 4
Period: 2012-02-09
Raptor Pharmaceutical CorpRPTP
Zankel Todd
Chief Scientific Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2012-02-09$2.83/sh+3,643$10,310→ 707,962 total
  • Exercise/Conversion

    Common Stock

    2012-02-09$2.02/sh+287$580→ 708,249 total
  • Sale

    Common Stock

    2012-02-09$7.65/sh−700$5,355→ 707,549 total
  • Sale

    Common Stock

    2012-02-09$7.66/sh−1,500$11,490→ 706,049 total
  • Sale

    Common Stock

    2012-02-09$7.71/sh−3,700$28,527→ 698,236 total
  • Sale

    Common Stock

    2012-02-09$7.72/sh−1,300$10,036→ 696,936 total
  • Sale

    Common Stock

    2012-02-09$7.74/sh−700$5,418→ 695,836 total
  • Sale

    Common Stock

    2012-02-09$7.83/sh−2,100$16,454→ 687,221 total
  • Sale

    Common Stock

    2012-02-09$7.67/sh−287$2,201→ 686,834 total
  • Exercise/Conversion

    Stock options (right to buy)

    2012-02-09+287→ 316,779 total
    Exercise: $2.02From: 2010-03-09Exp: 2020-03-08→ Common Stock (287 underlying)
  • Sale

    Common Stock

    2012-02-09$7.67/sh−1,470$11,275→ 703,136 total
  • Sale

    Common Stock

    2012-02-09$7.68/sh−600$4,608→ 702,536 total
  • Sale

    Common Stock

    2012-02-09$7.69/sh−300$2,307→ 702,236 total
  • Sale

    Common Stock

    2012-02-09$7.73/sh−400$3,092→ 696,536 total
  • Sale

    Common Stock

    2012-02-09$7.67/sh−1,443$11,068→ 704,606 total
  • Sale

    Common Stock

    2012-02-09$7.70/sh−300$2,309→ 701,936 total
  • Sale

    Common Stock

    2012-02-09$7.75/sh−2,600$20,150→ 693,236 total
  • Sale

    Common Stock

    2012-02-09$7.76/sh−200$1,552→ 693,036 total
  • Sale

    Common Stock

    2012-02-09$7.80/sh−1,400$10,920→ 691,636 total
  • Sale

    Common Stock

    2012-02-09$7.80/sh−200$1,561→ 691,436 total
  • Sale

    Common Stock

    2012-02-09$7.81/sh−1,500$11,715→ 689,936 total
  • Sale

    Common Stock

    2012-02-09$7.83/sh−615$4,815→ 689,321 total
  • Sale

    Common Stock

    2012-02-09$7.84/sh−100$784→ 687,121 total
  • Exercise/Conversion

    Stock options (right to buy)

    2012-02-09+3,643→ 317,066 total
    Exercise: $2.83From: 2006-11-25Exp: 2016-05-25→ Common Stock (3,643 underlying)
Footnotes (3)
  • [F1]Transaction made pursuant to a Rule 10b5-1 trading plan executed on January 9, 2012.
  • [F2]Original option grant vests 6/36ths on November 25, 2006 and 1/36th per month thereafter.
  • [F3]Original option grant vests 6/48ths on March 9, 2010 and 1/48th per month thereafter.

Documents

1 file

Issuer

Raptor Pharmaceutical Corp

CIK 0001070698

→
Entity typeother

Related Parties

1
  • filerCIK 0001362490

Filing Metadata

Form type
4
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 5:45 PM ET
Size
40.1 KB
View on SEC.gov